Ann Arbor, Michigan 48109

  • Substance Dependence

Purpose:

The purpose of this research study is to learn about how it can improve new counseling programs delivered by phone or video. This project will examine the feasibility and acceptability of motivational interviewing (MI) and cognitive behavioral therapy (CBT) interventions delivered via telehealth delivered treatment (Teletx). The goal is to refine the interventions to improve acceptability and feasibility and collect preliminary data for a fully powered randomized controlled trial (RCT) in the future. In addition to therapy sessions, participants that are enrolled in the study will complete surveys prior to, during, and after treatment.


Criteria:

Inclusion Criteria: - Outpatient care at Michigan Medicine in past year - Diagnostic and Statistical Manual of Mental Disorders (DSM-5) SUD diagnosis and/or substance use on average of 2 days a week over the past month - Have a Smart phone, tablet or another Wi-Fi or data-enabled device (e.g. with a camera) Exclusion Criteria: - Inability to speak or understand English - Conditions that preclude informed consent (e.g., acute psychosis, cognitive deficits) or understanding of assessment or program content - Prior alcohol withdrawal seizures or delirium tremens (DTs). Those who are at-risk of complicated withdrawal (e.g., seizures, DTs) require greater medical attention and will be excluded and referred to their clinician for medical management.


NCT ID:

NCT04768920


Primary Contact:

Principal Investigator
Allison Lin, MD
University of Michigan

Rachel Girard
Phone: 734-474-4278
Email: ragirard@umich.edu


Backup Contact:

Email: lmobley@med.umich.edu
Linda Mobley
Phone: 734-232-0298


Location Contact:

Ann Arbor, Michigan 48109
United States

Rachel Girard
Phone: 734-474-4278
Email: ragirard@umich.edu

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: June 24, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.